CClinicalTrials.gg
CompletedNCT06687915Updated Nov 14, 2024

Comparison of Balance and Coordination Parameters of Visually Impaired and Healthy Individuals

An observational study in Blindness Congenital, sponsored by Bahçeşehir University. Completed at 1 site in Turkey. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-11-14.

Sponsored by Bahçeşehir University · Observational

Study type
Observational
Model
Case-crossover
Time perspective
Prospective
Enrollment
38
Ages
18 Years to 40 Years
Sex
All
01

Study summary

The aim of this [observational study] is to examine balance in multiple aspects by comparing balance, coordination, and gait parameters between congenitally blind individuals and healthy individuals with multiple scales.

The main questions it aims to answer are:

Is there a difference in balance and coordination between congenitally blind individuals and healthy individuals? comparison group: Healthy sedated individuals Participants will be asked to complete balance scales.

Read the detailed description

Visually impaired, with all corrections, individuals who have one tenth of the usual visual acuity of the seeing eye, i.e. 20/200 visual acuity or less, or whose visual angle does not exceed 20 degrees are called blind. The meaning of 20/200 is that an individual affected by visual impairment can see from 60 cm, while an individual with normal vision can see from 6 m. Narrow angle of vision means that, despite normal visual acuity, vision is limited only to the centre, 20 degrees, and objects beyond 20 degrees cannot be seen.

Balance depends on the integration of information received from proprioceptive, vestibular and visual sensory systems. It has been observed that visually impaired individuals have problems in postural stability and balance due to insufficient information from the visual system. In this study, it was aimed to compare the balance, coordination and gait parameters of congenitally visually impaired individuals and healthy sedentary individuals.

02

Conditions studied

  • Blindness Congenital

Browse trials for

Keywords

  • Complete Blindness
  • Visual Impairments
  • Posture Balance
03

In context

Blindness

161 studies on the registry are indexed under Blindness; 33 are open to participants now.

This study's enrollment of 38 is below the median of 64 across 45 observational studies indexed under Blindness.

Browse Blindness studies →

Lead sponsor

Bahçeşehir University is the lead sponsor of 117 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

In this study, congenitally visually impaired individuals and healthy individuals aged between 18-40 years were included.

Inclusion criteria

  • 18 years of age or older
  • Congenital visual impairment
  • Not having any acute or chronic disease other than congenital blindness

Exclusion criteria

Exclusion Criteria:

  • Having musculoskeletal deformity
  • Being involved in a professional sport
  • Having received physiotherapy treatment for balance before
05

Study design

Observational model
Case-crossover
Time perspective
Prospective
Enrollment
38 participants (actual)
Patient registry
No

Groups and cohorts

  • Congenitally blind

    Individuals with congenital visual impairment were included in this group.

  • Healthy

    Healthy sedentary individuals were included in this group.

06

What researchers measure

Primary outcomes

  1. Berg Balance Test

    Berg Balance Scale was developed for postural control assessment. It includes 14 instructions and for each instruction, the patient's performance is observed and a score between 0-4 is given. It takes between 10 and 20 minutes to complete the scale

    Time frame: At the baseline of the study

07

Study locations

1 site
  • Avrasya University
    Trabzon, Ortahisar 61000, Turkey
08

References and documents

Publications

  • Blum L, Korner-Bitensky N. Usefulness of the Berg Balance Scale in stroke rehabilitation: a systematic review. Phys Ther. 2008 May;88(5):559-66. doi: 10.2522/ptj.20070205. Epub 2008 Feb 21. PubMed 18292215 ↗
  • Chen EW, Fu AS, Chan KM, Tsang WW. The effects of Tai Chi on the balance control of elderly persons with visual impairment: a randomised clinical trial. Age Ageing. 2012 Mar;41(2):254-9. doi: 10.1093/ageing/afr146. Epub 2011 Dec 16. PubMed 22180415 ↗
  • Gleeson M, Sherrington C, Lo S, Keay L. Can the Alexander Technique improve balance and mobility in older adults with visual impairments? A randomized controlled trial. Clin Rehabil. 2015 Mar;29(3):244-60. doi: 10.1177/0269215514542636. Epub 2014 Jul 15. PubMed 25027444 ↗

Individual participant data

Plan to share: No — It can be shared at the request of the researchers.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 14, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06687915
Lead sponsor
Bahçeşehir University
Responsible party
Alper Percin (Asst. Prof., Bahçeşehir University) — Principal investigator
First posted
Nov 14, 2024
Start date
Dec 25, 2022
Primary completion
Jul 22, 2023
Completion
Aug 1, 2023
Last update
Nov 14, 2024

Study contacts

Emine Atıcı, Assoc. Prof.
study director · Okan University
Alper Percin, Ph.D.
principal investigator · Bahçeşehir University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion